Webinars
Navigating Preclinical Drug Development Challenges with Lipid-Based Formulations
Summary: In this webinar experts share insights into critical considerations & strategies for dosing lipid formulations in preclinical models
View Now
Case Study
Enhancing Drug Performance Through Lipid-Based Formulations for CNS Indication
Read this case study to learn how a company engaged with Catalent to develop an oral lipid-based formulation that would lead to a more predictable and reliable drug response.
View Now
Webinars
Targeted Protein Degraders: Key strategies to Maximize VC Funding and Clinical Success
Summary: In this webinar, experts will explore the current investment and clinical landscape of Targeted Protein Degraders.
View Now
Executive Summary
Small Molecule Orphan Drugs: Status Quo, Challenges, and Perspectives
Summary: Experts explore the challenges of orphan drug development and manufacturing and will discuss how the industry is leveraging strategic partnerships to help mitigate these challenges to create a viable orphan drug business model.
View Now
Executive Summary
Targeted Protein Degraders: Through the Lens of the Innovation, Developability, and CMC Challenges
Summary: Experts review the trends and challenges associated with the rational design of targeted protein degrader drugs. In addition, experts also share perspectives on how to inform the selection and development of orally bioavailable...
View Now
eBook
Optimizing Highly Potent API Drug Development and Manufacturing
Summary: This eBook explores the challenges and strategies involved in developing and manufacturing HPAPIs as well as highlights the benefits of partnering with an experienced CDMO that can effectively address the challenges of manufacturing potent drugs and...
View Now
Webinars
Achieving Desired Particle Size and Yield Through Efficient Micronization
Summary: During this webinar learn with the right combination of technology and expertise, micronization can help to overcome many of the challenges faced by small molecule drugs and address the challenges and solutions to scale, yield and cost of goods.
View Now
Webinars
Preclinical Toxicology vs Clinical: Key Considerations in Using Lipid-based Formulations
Summary: In this webinar, experts offer insights into the perceived barriers to developing LBFs and recent advances in translating them into useful clinical and commercial products of lipophilic drugs.
View Now
Webinars
Targeted Protein Degraders: Through the Lens of the Innovation, Developability, and CMC Challenges
Summary: In this webinar, experts review the trends and challenges associated with the rational design of targeted protein degrader drugs.
View Now
Offering Fact Sheet
ProteoSuite℠ Oral
Summary: Comprehensive toolkit that offers a developability assessment specific to protein degraders.
View Now